Federation des caisses Desjardins du Quebec’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $383K | Buy |
1,303
+199
| +18% | +$56.4K | ﹤0.01% | 1451 |
|
|
2026
Q1 | $308K | Sell |
1,104
-405
| -27% | -$117K | ﹤0.01% | 1420 |
|
|
2025
Q4 | $457K | Buy |
1,509
+220
| +17% | +$68.6K | ﹤0.01% | 1328 |
|
|
2025
Q3 | $361K | Buy |
1,289
+1,279
| +12,790% | +$348K | ﹤0.01% | 1347 |
|
|
2025
Q2 | $2.41K | Sell |
10
-484
| -98% | -$114K | ﹤0.01% | 2386 |
|
|
2025
Q1 | $120K | Buy |
494
+157
| +47% | +$47.2K | ﹤0.01% | 1274 |
|
|
2024
Q4 | $111K | Hold |
337
| – | – | ﹤0.01% | 1248 |
|
|
2024
Q3 | $113K | Buy |
337
+115
| +52% | +$36.5K | ﹤0.01% | 1229 |
|
|
2024
Q2 | $60.6K | Buy |
222
+74
| +50% | +$21.5K | ﹤0.01% | 1351 |
|
|
2024
Q1 | $49.8K | Buy |
148
+79
| +114% | +$26K | ﹤0.01% | 1408 |
|
|
2023
Q4 | $22.3K | Hold |
69
| – | – | ﹤0.01% | 1546 |
|
|
2023
Q3 | $24.7K | Hold |
69
| – | – | ﹤0.01% | 1514 |
|
|
2023
Q2 | $26.2K | Hold |
69
| – | – | ﹤0.01% | 1513 |
|
|
2023
Q1 | $33.1K | Sell |
69
-201
| -74% | -$94.1K | ﹤0.01% | 1440 |
|
|
2022
Q4 | $114K | Hold |
270
| – | – | ﹤0.01% | 1233 |
|
|
2022
Q3 | $113K | Hold |
270
| – | – | ﹤0.01% | 1278 |
|
|
2022
Q2 | $134K | Hold |
270
| – | – | ﹤0.01% | 1246 |
|
|
2022
Q1 | $152K | Buy |
270
+2
| +0.7% | +$1.21K | ﹤0.01% | 1226 |
|
|
2021
Q4 | $202K | Sell |
268
-25
| -9% | -$18.7K | ﹤0.01% | 1154 |
|
|
2021
Q3 | $218K | Sell |
293
-38
| -11% | -$28.5K | ﹤0.01% | 1142 |
|
|
2021
Q2 | $213K | Sell |
331
-28
| -8% | -$17K | ﹤0.01% | 1163 |
|
|
2021
Q1 | $205K | Sell |
359
-2,341
| -87% | -$1.39M | ﹤0.01% | 1116 |
|
|
2020
Q4 | $1.57M | Buy |
+2,700
| New | +$1.54M | 0.02% | 521 |
|
|
2020
Q2 | – | Sell |
-8,354
| Closed | -$2.96M | – | 2125 |
|
|
2020
Q1 | $2.96M | Hold |
8,354
| – | – | 0.05% | 275 |
|
|
2019
Q4 | $3.09M | Hold |
8,354
| – | – | 0.04% | 326 |
|
|
2019
Q3 | $2.78M | Buy |
8,354
+3
| +0% | +$979 | 0.04% | 336 |
|
|
2019
Q2 | $2.6M | Hold |
8,351
| – | – | 0.04% | 342 |
|
|
2019
Q1 | $2.55M | Hold |
8,351
| – | – | 0.04% | 342 |
|
|
2018
Q4 | $1.94M | Hold |
8,351
| – | – | 0.03% | 410 |
|
|
2018
Q3 | $2.62M | Hold |
8,351
| – | – | 0.04% | 367 |
|
|
2018
Q2 | $2.41M | Buy |
8,351
+3,187
| +62% | +$880K | 0.04% | 394 |
|
|
2018
Q1 | $1.29M | Hold |
5,164
| – | – | 0.02% | 558 |
|
|
2017
Q4 | $1.23M | Buy |
+5,164
| New | +$1.25M | 0.02% | 581 |
|
|
2017
Q2 | – | Sell |
-1,855
| Closed | -$370K | – | 2160 |
|
|
2017
Q1 | $370K | Buy |
+1,855
| New | +$357K | 0.01% | 769 |
|
Other funds holding BIO
AI
Federation des caisses Desjardins du Quebec's BIO Position: Q2 2026 in Review
Federation des caisses Desjardins du Quebec increased its Bio-Rad Laboratories Class A (BIO) stake by 18% in Q2 2026, buying an estimated $56.4K and bringing the position to 1,303 shares worth $383K. The position accounts for ﹤0.01% of the portfolio, ranked #1451.
Federation des caisses Desjardins du Quebec first reported a position in BIO in Q1 2017 and has held it in 34 quarters since. The position peaked at $3.09M in Q4 2019. 400 funds tracked by Wall St. Rank hold BIO as of Q2 2026.
- Federation des caisses Desjardins du Quebec held 1,303 shares of Bio-Rad Laboratories Class A worth $383K as of Q2 2026.
- Federation des caisses Desjardins du Quebec bought 199 Bio-Rad Laboratories Class A shares in Q2 2026, an estimated $56.4K.
- Bio-Rad Laboratories Class A made up ﹤0.01% of Federation des caisses Desjardins du Quebec's portfolio in Q2 2026, its #1451 holding.
- Federation des caisses Desjardins du Quebec first reported a position in Bio-Rad Laboratories Class A in Q1 2017 and has held it in 34 quarters since.
- Federation des caisses Desjardins du Quebec's Bio-Rad Laboratories Class A position peaked at $3.09M in Q4 2019.
- 400 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2026.
Based on Federation des caisses Desjardins du Quebec's 13F filing for Q2 2026, filed 14 Aug 2026.